StratyPharma

Brussel ·KBO/BCE: BE 0769.613.935

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	86.3%	60.6%	better than 88% of 12464 sector peers
Net result	€43k	€31k	better than 60% of 12466 sector peers
Equity	€171k	€63k	better than 81% of 12472 sector peers
Gross operating margin	€61k	€52k	better than 56% of 12452 sector peers
Total assets	€199k	€124k	better than 67% of 12465 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€199k
Fixed assets	21/28	€2k
Tangible fixed assets	22/27	€2k
Current assets	29/58	€196k
Amounts receivable within one year	40/41	€8k
Investments	50/53	€165k
Cash & bank	54/58	€23k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€199k
Equity	10/15	€171k
Contributions / capital	10/11	€500
Reserves	13	€161k
Accumulated profits (losses)	14	€10k
Amounts payable	17/49	€27k
Amounts payable within one year	42/48	€27k
Trade debts payable within one year	44	€7
Income statement
Gross operating margin	9900	€61k
Operating result	9901	€58k
Financial income	75	€4k
Financial charges	65	€47
Result before taxes	9903	€62k
Income taxes	67/77	€20k
Net result for the period	9904	€43k
Result to be appropriated	9905	€43k

Summary